home / stock / tals / tals news

TALS News and Press, Talaris Therapeutics Inc. From 07/26/22

Stock Information
Company Name: Talaris Therapeutics Inc.
Stock Symbol: TALS
Market: NASDAQ
Menu
TALS TALS Quote TALS Short TALS News TALS Articles TALS Message Board
Get TALS Alerts

News, Short Squeeze, Breakout and More Instantly...
TALS - CMRX, VAPO and MNSO among mid-day movers

Gainers: GeoVax Labs ( GOVX ) +42% . InflaRx ( IFRX ) +37% . Sunshine Biopharma ( SBFM ) +35% . Nutriband ( NTRB ) +29% . Talaris Therapeutics ( TALS ) +24% . Chimerix ( CMRX ) +20% . Liberty TripAdvisor Holdings ...
TALS - Sunshine, InflaRx top healthcare gainers; Revelation, Virax lead losers' pack

Gainers: Sunshine Biopharma ( SBFM ) +26% . InflaRx IFRX +14% . Talaris Therapeutics ( TALS ) +8% . Nutriband ( NTRB ) +7% . Biodesix ( BDSX ) +5% . Losers: Revelation Biosciences REVB -52% . Virax Biolabs VR...

TALS - Inspira, Cano top healthcare gainers; Applied Molecular, HTG Molecular lead losers' pack

Gainers: Inspira Technologies Oxy ( IINN ) +98% . Cano Health CANO +18% . Veru VERU +16% . Amylyx Pharmaceuticals ( AMLX ) +13% . Equillium ( EQ ) +12% . Losers: Applied Molecular Transport AMTI -26% . HTG Molecular D...

TALS - Talaris cut to neutral at Morgan Stanley on safety concerns for kidney transplant drug

Morgan Stanley has downgraded Talaris Therapeutics ( NASDAQ: TALS ) to hold from buy amid late-stage results for its kidney transplant drug that indicate safety concerns. The firm has a $8 price target (~248% upside based on Friday's close). Despite the downgrade, shar...
TALS - Alpha Tau, Precigen top healthcare gainers; Revelation, Nemaura lead losers' pack

Gainers: Alpha Tau Medical ( DRTS ) +42% . Precigen ( PGEN ) +20% . Amylyx Pharmaceuticals ( AMLX ) +18% . bluebird bio ( BLUE ) +13% . Talaris Therapeutics ( TALS ) +11% . Losers: Revelation Biosciences ( REVB ...

TALS - CLVS, OMER and ALNA among mid-day movers

Gainers: Allena Pharmaceuticals ( ALNA ) +46% . Mega Matrix ( MTMT ) +43% . Faraday Future Intelligent Electric ( FFIE ) +30% . Tyra Biosciences ( TYRA ) +29% . Omeros ( OMER ) +28% . Clovis Oncology ( CLVS ) +22% . ...

TALS - Accolade, Clovis Oncology top healthcare gainers; Talaris Therapeutics leads losers

Gainers: Accolade ( ACCD ) +18% . Clovis Oncology ( CLVS ) +18% . Larimar Therapeutics ( LRMR ) +14% . Tyra Biosciences ( TYRA ) +13% . VectivBio Holding ( VECT ) +13% . Losers: Talaris Therapeutics ( TALS ) -48% . Agile Therapeu...
TALS - Talaris Therapeutics achieves positive results in phase 3 kidney transplant drug trial

Talaris Therapeutics ( NASDAQ: TALS ) said that its kidney transplant drug, FCR001, was successful in helping patients to wean off chronic anti-rejection drugs in a phase 3 trial . In an update, Talaris said that 24 patients have been enrolled in the trial. Three ...

TALS - Talaris Therapeutics Provides FREEDOM-1 Phase 3 Clinical Update

All three FREEDOM-1 patients treated with FCR001 who are more than 12 months post-transplant have been successfully weaned off chronic anti-rejection drugs All FREEDOM-1 patients who received FCR001 at least three months prior to the data cutoff date have achieved and mainta...

TALS - Abnormal Returns Of The Russell Index Reconstitution Anomaly: New 2022 Study

A new 2022/23 study continues the trading studies from 2017 testing abnormal Russell Index reconstitution returns from scholarly literature. Since 2017 the best return results from a price momentum test generated +57.90% in the first six months and average gains reached +29.04% in the...
Previous 10 Next 10